Professor Michael Haude, M.D., Director of Medizinische Klinik I, Lukaskrankenhaus, Neuss, Germany, served as the principal investigator for the study, which took place in Germany.
"We were very pleased with the ThromCat(TM) System performance during the study.
Not only did the system show itself to be safe and effective in removing thrombus in the coronary setting, it was also very easy to use.
I am very appreciative of the power of this device particularly in the large coronary arteries.
The device also appears to lessen the need for temporary pacing during these challenging procedures," commented Professor Haude